DSIJ Mindshare

India's One of the Women Entrepreneur Led Biotechnology Company's New Biosimilar in U.S. Gains Access to Over 100 Million Lives

The has given modest returns of 4.41 per cent over the past year. However, it has declined by 11.93 per cent over the last three years.

DSIJ Intelligence-2 0 177 Article rating: 4.1

The has given modest returns of 4.41 per cent over the past year. However, it has declined by 11.93 per cent over the last three years. 

The Indian Biotech Leader Expands its Operations in the U.S. Strategically Through the Launch of a New Biosimilar

Over the past year, Biocon delivered a return of 15.51 per cent, while its three-year return stood at -9.75 per cent.

DSIJ Intelligence-2 0 181 Article rating: 5.0

Over the past year, Biocon delivered a return of 15.51 per cent, while its three-year return stood at -9.75 per cent.

Pharma Stocks Under Pressure: Shares Drop Nearly 4 per cent Despite Diabetes and Obesity Drug Launch in UK

With GLP-1 therapies expected to be a significant revenue driver in the future, Biocon aims to strengthen its footprint in this segment.

DSIJ Intelligence 0 175 Article rating: 4.3

With GLP-1 therapies expected to be a significant revenue driver in the future, Biocon aims to strengthen its footprint in this segment.

This Pharma Stock Declines 4.86 per cent; Board Approves Rs 570 Crore Fundraise, Know the Stock Outlook Here

The Board of Directors approved the issuance of commercial papers worth Rs 570 crore on a private placement basis

DSIJ Intelligence 0 316 Article rating: 3.3

The Board of Directors approved the issuance of commercial papers worth Rs 570 crore on a private placement basis

Overnight Digest: Stocks to keep an eye on June 24

Auto stocks took the lead with BSE Auto Index adding up to 4 per cent. The top three auto stocks lifting the index were Maruti Suzuki, Here MotoCorp and Eicher Motors zooming up to 6.6 per cent.

DSIJ Intelligence 0 1637 Article rating: 3.2

Following the Asian market, the domestic indices opened on a positive note on Thursday. The markets cut some gains in the afternoon session but managed to remain in green.

RSS
123
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR